ALEXANDRIA, Va., May 26 -- United States Patent no. 12,636,382, issued on May 26, was assigned to University of Massachusetts (Westborough, Mass.).

"Prostate targeting adeno-associated virus serotype vectors" was invented by Guangping Gao (Worcester, Mass.), Jianzhong Ai (Worcester, Mass.), Hong Li (Worcester, Mass.) and Qiang Wei (Worcester, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The disclosure relates to compositions and methods for rAAV-mediated delivery of a transgene to a subject. In some embodiments, the rAAV transduces the prostate tissue of a subject. In some embodiments, the methods are useful for treatment of prostate disease (e.g., prostatitis, BPH, prostate cancer)."

The patent was...